Want to see IN:ARVEE full AI Analyst Report?
ARVEE Stock Chart & Stats
₹242.32
-₹0.03(-0.02%)
At close: 4:00 PM EST
₹242.32
-₹0.03(-0.02%)
Day’s Range― - ―
52-Week Range₹129.11 - ₹290.78
Previous CloseN/A
Volume716.00
Average Volume (3M)20.12K
Market Cap
₹2.08B
Enterprise Value₹1.45B
Total Cash (Recent Filing)₹32.82M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)51.4
Beta1.46
Next Earnings
Nov 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.68
Shares Outstanding11,020,000
10 Day Avg. Volume10,064
30 Day Avg. Volume20,116
Financial Highlights & Ratios
PEG Ratio3.35
Price to Book (P/B)4.37
Price to Sales (P/S)4.69
P/FCF Ratio-50.88
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage And Growing EquityVery low leverage and steadily rising equity give Arvee Laboratories meaningful financial flexibility. This reduces balance-sheet risk, supports resilience through weaker operating periods, and preserves capacity to fund operations or pursue growth without depending heavily on additional borrowing.
Positive ProfitabilityPositive profitability and an improved net margin indicate that the company continues to convert revenue into earnings despite recent sales volatility. Maintaining profitable operations provides an internal funding base and supports business durability if margins remain disciplined.
Strong Reported EPS GrowthThe reported EPS growth rate shows substantial earnings expansion in the measured period, strengthening the company’s earnings profile. If supported by continued operating profitability, this improvement can enhance reinvestment capacity and provide a stronger base for future performance.
Bears Say
Negative Recent Cash GenerationRecent negative operating and free cash flow indicate that accounting profitability is not currently translating into cash generation. Persistent cash absorption can restrict self-funded growth, reduce capital-allocation flexibility, and make operating performance more vulnerable if the trend continues.
Volatile And Declining RevenueRepeated revenue declines after the FY2023 surge point to unstable demand or pricing rather than a consistently expanding sales base. This volatility makes future earnings less predictable, can weaken operating leverage, and complicates planning for investment and capacity.
Pressure On Operating MarginsAlthough operations remain profitable, the decline from the FY2023 margin peak reduces the cushion protecting earnings from further revenue weakness. Lower operating profitability can constrain reinvestment and leave future earnings more sensitive to changes in sales volume or pricing.
Arvee Laboratories (India) Ltd. News
ARVEE FAQ
What was Arvee Laboratories (India) Ltd.’s price range in the past 12 months?
Arvee Laboratories (India) Ltd. lowest stock price was ₹129.11 and its highest was ₹290.78 in the past 12 months.
What is Arvee Laboratories (India) Ltd.’s market cap?
Arvee Laboratories (India) Ltd.’s market cap is ₹2.08B.
When is Arvee Laboratories (India) Ltd.’s upcoming earnings report date?
Arvee Laboratories (India) Ltd.’s upcoming earnings report date is Nov 06, 2026 which is in 12 days.
How were Arvee Laboratories (India) Ltd.’s earnings last quarter?
Arvee Laboratories (India) Ltd. released its earnings results on Aug 07, 2026. The company reported ₹1.537 earnings per share for the quarter.
Is Arvee Laboratories (India) Ltd. overvalued?
According to Wall Street analysts Arvee Laboratories (India) Ltd.’s price is currently Overvalued.
Does Arvee Laboratories (India) Ltd. pay dividends?
Arvee Laboratories (India) Ltd. does not currently pay dividends.
What is Arvee Laboratories (India) Ltd.’s EPS estimate?
Arvee Laboratories (India) Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Arvee Laboratories (India) Ltd. have?
Arvee Laboratories (India) Ltd. has 11,020,000 shares outstanding.
What happened to Arvee Laboratories (India) Ltd.’s price movement after its last earnings report?
Arvee Laboratories (India) Ltd. reported an EPS of ₹1.537 in its last earnings report. Following the earnings report the stock price went up 0.527%.
Which hedge fund is a major shareholder of Arvee Laboratories (India) Ltd.?
Currently, no hedge funds are holding shares in IN:ARVEE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Arvee Laboratories (India) Ltd.
Arvee Laboratories (India) Ltd., established in 2012 and headquartered in Ahmedabad, India, specializes in the production and distribution of various specialized chemicals throughout the country. The company's product line includes a range of polymer modifiers, such as dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate. Additionally, Arvee Laboratories manufactures intermediates critical for contrast media, supplying compounds like 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, dimethyl 5-aminoisophthalate, 3,5-dinitrobenzoic acid, and 3,5-diamino benzoic acid. The firm also provides drug intermediates, specifically 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4-amino pyridine, and 2-chloro-5-nitrobenzoic acid. Beyond its domestic sales, Arvee Laboratories actively exports its chemical products.
Technical Analysis
AksharChem India Ltd.
―
Poddar Pigments Limited
―
Shankar Lal Rampal Dye-Chem Ltd.
―
Tainwala Chemicals & Plastics (India) Ltd
―
Vineet Laboratories Ltd.
―